NextGen Customer Engagement Platform: Empowering Digital Transformation in the Pharmaceutical Industry
On November 6th, AstraZeneca, Tencent Health, and Accenture jointly announced the launch of the NextGen Customer Engagement Platform at the 6th China International Import Expo. This collaboration aims to assist AstraZeneca China in creating a future-oriented GoToMarket business model, integrating customer management and engagement through an innovative platform ecosystem.
AstraZeneca, a globally renowned biopharmaceutical company driven by innovation, has been operating in the Chinese market for 30 years. In this new phase of development, AstraZeneca prioritizes patient-centric approaches and leverages technology to explore the possibilities of digital healthcare. Together with its partners, the company aims to enhance integrated diagnosis and treatment solutions, enable comprehensive care management, and introduce fresh perspectives to chronic disease management, primary healthcare, and multi-scenario medical services.
The NextGen Customer Engagement Platform:
The NextGen Customer Engagement Platform emerges in this context. This collaboration revolves around three core concepts: an integrated user experience centered around healthcare professionals (HCPs), data-driven business decision-making, and the establishment of a platform ecosystem. The platform aims to support digital healthcare development comprehensively, encompassing communication efficiency, cross-department collaboration, data insights, and intelligent decision-making.
Tencent's Contribution:
Leveraging its leading expertise in artificial intelligence, big data, and cloud computing, Tencent is committed to enhancing efficient communication and collaboration between medical enterprises and healthcare professionals. Tencent Health's Next Generation Engagement Solution (NGES), built on Tencent Cloud's infrastructure, cloud-native architecture, and digital security capabilities, seamlessly integrates IaaS, PaaS, and SaaS layers. The solution incorporates CRM, Events, and MCM tools, providing a cloud-based end-to-end solution for pharmaceutical marketing. With innovation as its driving force, Tencent Health aims to facilitate the healthy and sustainable development of the pharmaceutical industry.
Future Prospects:
Looking ahead, Tencent Health plans to provide comprehensive solutions across the value chain of pharmaceutical enterprises. Through powerful technological advancements and product ecosystems, the company will optimize the allocation and utilization of medical resources. By embracing an open and forward-thinking approach, Tencent Health aims to support the digital transformation of enterprises through continuous exploration and research and development.
The collaboration between AstraZeneca, Tencent Health, and Accenture marks a significant milestone in the digital transformation of the pharmaceutical industry. The NextGen Customer Engagement Platform brings together cutting-edge technologies, data-driven insights, and an innovative ecosystem, empowering AstraZeneca China to create a future-oriented business model and revolutionize customer management and engagement. With Tencent Health's expertise and solutions, the pharmaceutical industry is poised to achieve high-quality and sustainable development in the era of digitalization.
2026-10-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Tencent Tang Daosheng: Accelerate the embrace of digital health and activate the endogenous power of the industry
-
Tencent's AI drug discovery platform breaks through the closed-loop capability of high-throughput dry and wet experiments
-
Tencent Cloud officially released two new solutions of intelligent manufacturing
-
ANVISA Updates Additive Rules
-
Fertilizer Prices Put U.S. Farmers Under Pressure
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Prepares New Seed and Pesticide Laws
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Behind Japan's Tungsten Hexafluoride Crisis: Can China's Electronic Specialty Gases Seize a New Opportunity?
-
TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
Recommend Reading
-
BASF Raises European NPG and HDO Prices by Up to €300/Tonne as Costs Climb
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
Qatar LNG Supply Disruption Persists for Nearly Six Months, Exports Plunge 96%
-
Business Society’s Market Outlook for Propylene Oxide on August 12, 2026: Price Trends Clearly Declining
-
Business Society’s Market Outlook for Epichlorohydrin on August 12, 2026: Price Trends Clearly Declining
-
Premium Global Chemical Sourcing Requests (12 - 16 Mar, 2026)
-
In early August, the n-butanol market in Shandong, China, experienced a slight decline
-
Syngenta Caught in Trade Crossfire
- Hot Searches
- reta weight loss where to buy
- dimethyl terephthalate powder
- active pharmaceutical ingredients bestellen
- epoxy resin chemical formula
- n-isopropylbenzylamine for sale
- ammonium sulfide
- emamectin benzoate for sale
- butyl glycol suppliers
- methyl acrylate
- sodium acetate sds
- ammonium sulafte
- bioglutide buy online